ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,364Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 663

$522K Total Retail Price of All Prescriptions

Rank: 60 out of 663

579 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 579 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

4% of this provider’s 579 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 9,647 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 640 579 1 3
SIMVASTATIN 622 569 2 1
LISINOPRIL 548 460 3 2
OMEPRAZOLE 386 320 4 4
TRAMADOL HCL 367 294 5 17
FUROSEMIDE 356 322 6 7
AMLODIPINE BESYLATE 344 311 7 5
WARFARIN SODIUM 255 233 8 8
METFORMIN HCL 238 190 9 9
METOPROLOL TARTRATE 203 188 10 11
SERTRALINE HCL 168 140 11 35
HYDROCHLOROTHIAZIDE 165 163 12 12
ATORVASTATIN CALCIUM 163 136 13 13
HYDROCODONE-ACETAMINOPHEN 143 112 S3 14 6
ATENOLOL 140 137 15 10
CLONIDINE HCL 138 133 16 79
TRAZODONE HCL 135 103 17 34
GABAPENTIN 135 122 17 20
TAMSULOSIN HCL 131 101 19 24
POTASSIUM CHLORIDE 125 121 20 23
MELOXICAM 124 109 21 61
METOPROLOL SUCCINATE 121 108 22 25
AMITRIPTYLINE HCL 112 76 R 23 95
PANTOPRAZOLE SODIUM 111 83 24 45
CYMBALTA 104 48 25 54
ALENDRONATE SODIUM 103 102 26 15
LOSARTAN POTASSIUM 98 88 27 14
DONEPEZIL HCL 96 92 28 40
CITALOPRAM HBR 93 73 29 18
PREDNISONE 92 86 30 39
GLYBURIDE 91 78 R 31 83
CYCLOBENZAPRINE HCL 89 31 R 32 71
PRAVASTATIN SODIUM 82 65 33 21
GLIPIZIDE 77 58 34 29
FLUTICASONE PROPIONATE 77 67 34 27
ADVAIR DISKUS 73 70 36 53
ZOLPIDEM TARTRATE 72 54 37 16
TRIAMTERENE-HCTZ 71 70 38 42
ALLOPURINOL 70 69 39 28
CARVEDILOL 70 58 39 47
TERAZOSIN HCL 69 59 41 38
METOCLOPRAMIDE HCL 64 53 42 182
DIGOXIN 63 63 43 50
KLOR-CON M20 63 63 43 70
NEXIUM 60 37 45 43
LOSARTAN-HYDROCHLOROTHIAZIDE 59 59 46 60
NAMENDA 56 53 47 57
ISOSORBIDE MONONITRATE ER 55 55 48 93
BUMETANIDE 54 53 49 110
PLAVIX 52 46 50 104
CLOPIDOGREL 52 48 50 65
MIRTAZAPINE 51 51 52 52
FENTANYL 51 51 S2 52 75
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 50 54 22
LABETALOL HCL 50 50 54 170
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 2, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.